Arcus Biosciences · 2 weeks ago
Drug Metabolism Pharmacokinetics (DMPK) - LC-MS Intern
Arcus Biosciences is a company focused on drug discovery and development, particularly in the DMPK department. They are seeking interns to gain hands-on experience in small molecule bioanalysis and data processing, assisting in the development of LC-MS methods and workflows for metabolite identification.
Responsibilities
Develop and optimize high-throughput LC-MS methods using serum albumin columns to evaluate compound plasma protein binding in human and preclinical species
Assist in building MetID data analysis workflow using Compound Discoverer software
Perform routine lab activities including sample preparation, data collection and analysis
Maintain accurate experimental records
Qualification
Required
Complete or enroll in a Master's or PhD program in Pharmaceutical Sciences, Analytical Chemistry or a related field
Basic wet-lab experience is required
Excellent written and verbal communication skills
Ability to learn quickly and work in a team environment
This intern position is 40 hours per week located on our Hayward, CA Campus
All applicants must be actively enrolled in an accredited academic program for Fall 2026
Preferred
Hands-on experiences in LC-MS are preferred
Prior internship or research experience in DMPK or related fields is a plus
Company
Arcus Biosciences
Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.
H1B Sponsorship
Arcus Biosciences has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (14)
2024 (15)
2023 (18)
2022 (20)
2021 (15)
2020 (10)
Funding
Current Stage
Public CompanyTotal Funding
$1.52BKey Investors
Hercules CapitalGilead SciencesGoogle Ventures
2025-10-30Post Ipo Equity· $250M
2025-02-18Post Ipo Equity· $150M
2024-08-27Post Ipo Debt· $150M
Recent News
2025-12-18
2025-12-16
Company data provided by crunchbase